ReviewInfectious diseases and therapy2026
Dengue Vodcast: Insights from Recent Infectious Disease Congresses.
Review in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is the most common vector-borne viral disease. Dengue virus belongs to the Flaviviridae family, and it is predominantly transmitted by Aedes aegypti and Aedes albopictus mosquitoes. Dengue is a global threat to public health, with hundreds of millions of infections each year. Not only is the incidence of dengue increasing, but the geographic areas at risk are also expanding, with outbreaks in areas that have never reported dengue cases in the past, such as North America and Europe. In this vodcast, Professor Marco Aurélio Sáfadi, a pediatric infectious diseases specialist and associate professor at Santa Casa de São Paulo, Brazil, discusses key highlights of current dengue research from selected congresses held in 2025-the World Congress of the World Society for Pediatric Infectious Diseases, the American Society of Tropical Medicine and Hygiene, and the Latin American Congress of Pediatric Infectious Disease. The aim of the vodcast is to communicate the latest scientific findings and provide insights into their clinical significance. The vodcast covers a wide range of topics relating to dengue, including vaccination, surveillance and control, prophylaxis, diagnosis, management, predicting disease progression, and immune responses during dengue infection. Data from these congresses highlight the key role dengue vaccines play in disease prevention, and how vector control methods, like Wolbachia, can help reduce the spread of the disease. They also highlight the need for an integrated approach to targeting dengue, bringing together advanced diagnostic and prognostic tools, vector control techniques, and novel therapeutic and disease management strategies.Vodcast available for this article. Podcast Audio (MP4 1271498 KB).
Indexed as
Identifiers
42728467What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.